Trying to weigh the best options for the way forward.
My father has been diagnosed with Metastatic Prostate Cancer. It's a case of acinar adenocarcinoma of the prostate. He underwent a bilateral orchidectomy (2018) and started Bicalutamide. Post- Radiotherapy (last on 22.11.2023). Post- 6 cycles of chemotherapy. Now presented with severe back pain for the last 10 days. A PET-CT scan was done on 6th March 2024 for disease status evaluation.
PET-CT scan findings reveal :
- Metabolically active abdominopelvic lymph nodes.
- Metabolically active lesions were noted in the body of the D10 vertebra and the right transverse process of the D9 vertebra.
- No other FDG avid visible disease is seen elsewhere in the regions of the body surveyed.
We are in Delhi, India and are under consultation at Rajiv Gandhi Cancer Institute & Research Centre and are planning to initiate lutetium therapy there.
I trust the doctor's recommendation, but trying to understand from the members of this community if Lu177 treatment (which is not too common yet in India) has resulted in a better way of living as compared to other chemotherapy options available.